Skip to main content
Skin & hairSignal peptide

Tripeptide-10 Citrulline

Also known as: Decorinyl

By the Peptide Dossier Editorial TeamUpdated How we source

Tripeptide-10 citrulline is a decorin-inspired cosmetic signal peptide. Laboratory collagen-organization findings and manufacturer claims do not establish independent human appearance efficacy.

Quick Facts

Class:Signal peptide
US product context:Cosmetic ingredient, not an FDA-approved therapeutic drug.
Evidence context:Laboratory/tissue-culture and manufacturer findings; no independent human efficacy trial.

Identity and decorin rationale

This synthetic ingredient combines three amino acids with a citrulline group. It mimics decorin, a small skin protein that attaches to collagen and influences fiber organization. Lubrizol markets it as Decorinyl, with roots in Lipotec research. It is a cosmetic ingredient rather than a medicine.

Collagen-organization mechanism

The proposed action concerns collagen assembly rather than simply increasing collagen quantity. In-vitro work found regulation of fiber diameter, supporting the hypothesis of more uniform spacing and structure. Because decorin becomes fragmented in aged skin, a decorin-like signal is proposed to support smoother-looking skin.

These are laboratory observations. Finished-product goals concern the appearance of texture and firmness, not demonstrated clinical rebuilding of collagen.

Cosmetic uses and regulatory boundary

Serums and creams use it for smoother-looking texture, suppleness and firmness, often framed as collagen quality and combined with moisturizing ingredients or other peptides.

Cosmetic ingredients are not preapproved by FDA. A claim about appearance differs from a therapeutic claim to reorganize body collagen, which would place a product in drug territory.

Evidence and tolerability

Tripeptide-10 citrulline evidence
Evidence sourceWhat it supports
Founding laboratory/tissue-culture studyRegulation of collagen-fiber formation, not a clinical appearance trial.
Frequently cited manufacturer dataImproved suppleness with a low-concentration cream in a small group; not an independently published trial.

No independent human efficacy study is described. Low cosmetic concentrations are generally reported as well tolerated with low irritation potential, but independent safety data are limited. Sensitive skin warrants a patch test.

Sources: [1]

References and further reading

This reference draws on Superpower’s Peptide Library and the research linked below. Peptide Dossier’s editorial team adapted and integrated the material on .

  1. 10.1111/j.1468-2494.2008.00429.xEvidence and tolerabilityCited in: Evidence and tolerability

Frequently Asked Questions About Tripeptide-10 Citrulline

Related Peptides

Continue exploring Tripeptide-10 Citrulline

Search all related references →

Our library review is ongoing. Read how we evaluate evidence or report a correction.

Disclaimer: This article is for informational and educational purposes only. It is not intended as medical advice. The information presented is based on published research and should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting any peptide protocol. Some peptides discussed may not be approved for human use by the FDA or equivalent regulatory bodies.